Sepiapterin

DRUG2 trials

Sponsors

PTC Therapeutics, Birmingham Women's and Children's NHS Foundation Trust

Conditions

Phenylketonuria

Phase 3

A Study of Sepiapterin in Participants With Phenylketonuria (PKU)

RecruitingNCT06302348

PTC TherapeuticsPhenylketonuria

Start: 2024-03-04End: 2031-02-28Target: 56Updated: 2026-08-28

Unknown Phase

Impact Of A Phe-Restricted Diet On Gut Health In Children With PKU

RecruitingNCT07728032

Birmingham Women's and Children's NHS Foundation TrustPhenylketonuria

Start: 2025-10-01End: 2026-12-01Target: 148Updated: 2026-07-27